362 related articles for article (PubMed ID: 12206801)
1. The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
Perkins KJ; Davies KE
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S78-89. PubMed ID: 12206801
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy.
Krag TO; Gyrd-Hansen M; Khurana TS
Acta Physiol Scand; 2001 Mar; 171(3):349-58. PubMed ID: 11412148
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
4. The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.
Perkins KJ; Burton EA; Davies KE
Nucleic Acids Res; 2001 Dec; 29(23):4843-50. PubMed ID: 11726694
[TBL] [Abstract][Full Text] [Related]
5. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin.
Louboutin JP; Rouger K; Tinsley JM; Halldorson J; Wilson JM
Mol Med; 2001 May; 7(5):355-64. PubMed ID: 11474581
[TBL] [Abstract][Full Text] [Related]
6. [Utrophin, a way to cure Duchenne muscle dystrophy].
Gillis JM
Med Sci (Paris); 2004 Apr; 20(4):442-7. PubMed ID: 15124117
[TBL] [Abstract][Full Text] [Related]
7. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice.
Gillis JM
Acta Neurol Belg; 2000 Sep; 100(3):146-50. PubMed ID: 11098286
[TBL] [Abstract][Full Text] [Related]
8. [Future treatment modalities in Duchenne muscular dystrophy].
Oron A; Shuper A; Shohat M
Harefuah; 1998 Apr; 134(7):557-60. PubMed ID: 10909603
[No Abstract] [Full Text] [Related]
9. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
[TBL] [Abstract][Full Text] [Related]
10. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?
Wells DJ; Wells KE
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S11-22. PubMed ID: 12206790
[TBL] [Abstract][Full Text] [Related]
13. A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
Weir AP; Morgan JE; Davies KE
Neuromuscul Disord; 2004 Jan; 14(1):19-23. PubMed ID: 14659408
[TBL] [Abstract][Full Text] [Related]
14. A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy.
Burton EA; Tinsley JM; Holzfeind PJ; Rodrigues NR; Davies KE
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14025-30. PubMed ID: 10570192
[TBL] [Abstract][Full Text] [Related]
15. The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin.
Porter JD; Rafael JA; Ragusa RJ; Brueckner JK; Trickett JI; Davies KE
J Cell Sci; 1998 Jul; 111 ( Pt 13)():1801-11. PubMed ID: 9625743
[TBL] [Abstract][Full Text] [Related]
16. Utrophin therapy for Duchenne muscular dystrophy?
Nelson R
Lancet Neurol; 2004 Nov; 3(11):637. PubMed ID: 15515235
[No Abstract] [Full Text] [Related]
17. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
[TBL] [Abstract][Full Text] [Related]
18. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
Ito M; Ehara Y; Li J; Inada K; Ohno K
Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
[TBL] [Abstract][Full Text] [Related]
19. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice.
Deconinck N; Tinsley J; De Backer F; Fisher R; Kahn D; Phelps S; Davies K; Gillis JM
Nat Med; 1997 Nov; 3(11):1216-21. PubMed ID: 9359695
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
